These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1370701)

  • 1. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
    Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
    Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
    Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
    Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia.
    Thompson SJ; Mellon K; Charlton RG; Marsh C; Robinson M; Neal DE
    Br J Urol; 1992 Jun; 69(6):609-13. PubMed ID: 1379102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ; George E; Lindgren BR; Niehans GA
    Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
    Gale N; Zidar N; Kambic V; Poljak M; Cör A
    Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
    Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
    Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue.
    Turkeri LN; Sakr WA; Wykes SM; Grignon DJ; Pontes JE; Macoska JA
    Prostate; 1994 Oct; 25(4):199-205. PubMed ID: 7521960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
    Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP
    Prostate; 1993; 23(4):329-36. PubMed ID: 7505056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
    J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
    Jaros E; Perry RH; Adam L; Kelly PJ; Crawford PJ; Kalbag RM; Mendelow AD; Sengupta RP; Pearson AD
    Br J Cancer; 1992 Aug; 66(2):373-85. PubMed ID: 1503912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
    Giri DK; Pal R; Wadhwa SN; Talwar GP
    Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours.
    Harper ME; Goddard L; Glynne-Jones E; Peeling WB; Griffiths K
    Eur J Cancer; 1995; 31A(9):1492-7. PubMed ID: 7577078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.